Trial Profile
A Phase III Randomized Double-blind Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Prednisolone
- Indications Tennis elbow
- Focus Therapeutic Use
- Acronyms EPITOX
- 13 Apr 2023 Status changed from suspended to completed.
- 21 Mar 2022 Planned End Date changed from 1 Oct 2021 to 1 Oct 2022.
- 21 Mar 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2022.